Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN PUERTO RICOThe outcome of the upcoming elections is expected to assist in shaping the development of Puerto Rico's healthcare and pharmaceutical markets, depending on the direction of the new governor's economic policies. Nevertheless, we do not expect a return to the historically - high annual rates of pharmaceutical spending, especially as the government now covers less than 40% of the territory's overall healthcare spending. In the meantime, the territory will remain an important pharmaceutical and medical devices production base, although its attractiveness has been on the wane for some time now.Headline Expenditure ProjectionsPharmaceuticals: US$2.81bn in 2011 to US$2.88bn in 2012; +2.5% in local currency terms. Forecast unchanged from Q4 12.Healthcare: US$11.27bn in 2011 to US$11.67bn in 2012; +3.6% in local currency terms. Forecast unchanged from Q4 12.Medical devices: US$536mn in 2011 to US$541mn in 2012; +0.9% in local currency terms. Forecast unchanged from Q4 12.Risk/Reward Rating: Puerto Rico again remains third in our proprietary Pharmaceutical Risk/Reward Ratings (RRRs) matrix for the Americas in Q113, ranking behind the US and Canada. Its composite score is also an unchanged 65.6 out of the maximum 100, comprising evenly-balanced risk and reward components. In the medium to longer term, Puerto Rico's high matrix placement will come under increased pressure due to factors such as its small population, uneasy economic prospects and competition from emerging markets in Latin America. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Puerto Rico
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN PUERTO RICO
The outcome of the upcoming elections is expected to assist in shaping the development of Puerto Rico's healthcare and
pharmaceutical markets, depending on the direction of the new governor's economic policies. Nevertheless, we do not expect a return
to the historically - high annual rates of pharmaceutical spending, especially as the government now covers less than 40% of the
territory's overall healthcare spending. In the meantime, the territory will remain an important pharmaceutical and medical devices
production base, although its attractiveness has been on the wane for some time now.
Headline Expenditure Projections
Pharmaceuticals: US$2.81bn in 2011 to US$2.88bn in 2012; +2.5% in local currency terms. Forecast unchanged from Q4 12.
Healthcare: US$11.27bn in 2011 to US$11.67bn in 2012; +3.6% in local currency terms. Forecast unchanged from Q4 12.
Medical devices: US$536mn in 2011 to US$541mn in 2012; +0.9% in local currency terms. Forecast unchanged from Q4 12.
Risk/Reward Rating: Puerto Rico again remains third in our proprietary Pharmaceutical Risk/Reward Ratings (RRRs) matrix for the
Americas in Q113, ranking behind the US and Canada. Its composite score is also an unchanged 65.6 out of the maximum 100,
comprising evenly-balanced risk and reward components. In the medium to longer term, Puerto Rico's high matrix placement will
come under increased pressure due to factors such as its small population, uneasy economic prospects and competition from
emerging markets in Latin America.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
Puerto Rico Pharmaceuticals And Healthcare Industry SWOT 7
Pharmaceutical Risk/Reward Ratings 8
Table: Americas Pharmaceutical Risk/Reward Ratings, Q113 8
Rewards 9
Risks 9
Puerto Rico ' Market Summary 11
Regulatory Regime 13
The Pharmaceutical Market: Puerto Rico (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Pricing And Reimbursement Issues 14
Tax Incentives 14
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers 16
Trade Accords 17
Industry Developments 18
Epidemiology 18
Healthcare Sector 19
Effects Of US Healthcare Reform 21
Healthcare Financing 22
Healthcare Provision 24
Research & Development 24
Biotechnology 26
Clinical Trials 27
Medical Devices 28
Industry Forecast Scenario 30
Pharmaceutical Market Forecast 30
Table: Pharmaceutical Sales Indicators 2008-2016 31
Healthcare Market Forecast 32
Table: Healthcare Expenditure Indicators 2008-2016 33
Table: Healthcare Governmental Indicators 2008-2016 33
Table: Healthcare Private Indicators 2008-2016 34
Key Growth Factors ' Macroeconomic 34
Prescription Drug Market Forecast 36
Table: Prescription Drug Sales Indicators 2008-2016 36
Patented Drug Market Forecast 37
Table: Patented Drug Market Indicators 2008-2016 38
Generic Drug Market Forecast 38
Table: Generic Drug Sales Indicators 2008-2016 39
OTC Medicine Market Forecast 40
Table: OTC Medicine Sales Indicators 2008-2016 41
Pharmaceutical Trade Forecast 41
Table: Exports and Imports Indicators 2008-2016 44
Medical Device Market Forecast 45
Table: Medical Devices Sales Indicators 2008-2016 46
Other Healthcare Data Forecasts 46
Key Risks To BMI's Forecast Scenario 46
Competitive Landscape 48
Pharmaceutical Industry 49
Table: Major International Drugmakers In Puerto Rico 50
Pharmaceutical Production 52
Plant Closures 54
Table: Puerto Rico: Multinational Downscaling 54
Company Developments 55
Pharmaceutical Wholesale 58
Pharmaceutical Retail 58
Company Profiles 61
Pfizer 61
GlaxoSmithKline 63
The Pharmaceutical Market: Puerto Rico (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Merck & Co 65
Abbott Laboratories 67
Novartis 69
Sanofi-Aventis 70
Eli Lilly 71
Johnson & Johnson (J&J) 73
Demographic Outlook 75
Table: Puerto Rico's Population By Age Group, 1990-2020 ('000) 76
Table: Puerto Rico's Population By Age Group, 1990-2020 (% of total) 77
Table: Puerto Rico's Key Population Ratios, 1990-2020 78
Table: Puerto Rico's Rural And Urban Population, 1990-2020 78
Glossary 79
BMI Methodology 81
How We Generate Our Pharmaceutical Industry Forecasts 81
Risk/Reward Ratings Methodology 82
Ratings Overview 82
Table: Pharmaceutical Business Environment Indicators 83
Weighting 84
Table: Weighting Of Components 84
Sources 84
The Pharmaceutical Market: Puerto Rico (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Puerto Rico
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Puerto Rico (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Puerto Rico (From Slideshare) Page 5/5